Sanofi, Novartis, and GSK prioritize Patient-Reported Outcomes

« Back to Previous Page
▲
83
▼
♥ 0

Clinical trials are no longer about hard clinical endpoints. Payers are increasingly demanding patient-centered outcomes as a prerequisite to approve…

Please to read the entire article.

Marked as spam
Posted by Raman Sehgal (Discussions: 3, Comments: 0)
Replied on July 12, 2018 12:00 am
Category: Clinical & Molecular Diagnostics
8 views
« Back to Previous Page